Format

Send to

Choose Destination
Lancet Oncol. 2019 Nov;20(11):1479-1481. doi: 10.1016/S1470-2045(19)30627-8. Epub 2019 Sep 28.

CDK4/6 inhibitors in breast cancer: a role in triple-negative disease?

Author information

1
Cancer Research Division, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Medical Oncology, University of Melbourne, Melbourne, VIC, Australia.
2
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA. Electronic address: sara_tolaney@dfci.harvard.edu.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center